Abstract:Jain Koo, 1, 2 Chaemin Lim, 3 Kyung Taek Oh 1, 2 1 Department of Global Innovative Drugs, The Graduate School of Chung-Ang University, Seoul, Republic of Korea; 2 College of Pharmacy, Chung-Ang University, Seoul, Republic of Korea; 3 College of Pharmacy, CHA University, Seongnam-si, Gyeonggi-do, Republic of Korea Correspondence: Kyung Taek Oh; Chaemin Lim, Tel/Fax +82-2-824-5617, Email ; Addressing disorders related to the central nervous system (CNS) remains a complex challenge because of the presence of the blood-brain barrier (BBB), which restricts the entry of external substances into the brain tissue. Consequently, finding ways to overcome the limited therapeutic effect imposed by the BBB has become a central goal in advancing delivery systems targeted to the brain. In this context, the intranasal route has emerged as a promising solution for delivering treatments directly from the nose to the brain through the olfactory and trigeminal nerve pathways and thus, bypassing the BBB. The use of lipid-based nanoparticles, including nano/microemulsions, liposomes, solid lipid nanoparticles, and nanostructured lipid carriers, has shown promise in enhancing the efficiency of nose-to-brain delivery. These nanoparticles facilitate drug absorption from the nasal membrane. Additionally, the in situ gel (ISG) system has gained attention owing to its ability to extend the retention time of administered formulations within the nasal cavity. When combined with lipid-based nanoparticles, the ISG system creates a synergistic effect, further enhancing the overall effectiveness of brain-targeted delivery strategies. This comprehensive review provides a thorough investigation of intranasal administration. It delves into the strengths and limitations of this specific delivery route by considering the anatomical complexities and influential factors that play a role during dosing. Furthermore, this study introduces strategic approaches for incorporating nanoparticles and ISG delivery within the framework of intranasal applications. Finally, the review provides recent information on approved products and the clinical trial status of products related to intranasal administration, along with the inclusion of quality-by-design–related insights. Keywords: nose to brain delivery system, lipid based nanoparticle, in situ gel, bypassing BBB Global healthcare data indicate a significant increase in the prevalence of central nervous system (CNS) diseases, which contribute approximately 6–8% to the global economy. 1 Over time, the incidence of conditions such as Alzheimer's disease, Parkinson's disease, schizophrenia, multiple sclerosis, and CNS cancers has markedly increased. 2–6 Despite this trend, conventional treatments for CNS disorders have predominantly relied on administration routes that target peripheral areas, such as oral and parenteral methods. 7 However, the efficacy of therapeutic agents faces considerable hurdles due to the complex blood-brain barrier (BBB). Although intracerebroventricular injection has emerged as an alternative approach, its invasive nature, associated discomfort, and limited practicality have restricted its use to specialized medical contexts. The BBB is a highly specialized and tightly regulated semipermeable barrier that separates circulating blood from the brain's extracellular fluid. 8–11 It is primarily composed of endothelial cells lining the blood vessels in the brain and is surrounded by additional support cells such as astrocytes. The BBB plays a crucial role in maintaining the microenvironment of the brain by controlling the passage of substances between the blood and brain tissue. This barrier selectively allows essential nutrients and molecules to pass through, while restricting the entry of potentially harmful substances, pathogens, and most large molecules. Its unique structure and function make it a significant challenge to deliver drugs and therapeutic agents to the brain, requiring innovative strategies for the effective treatment of CNS disorders. Therefore, intranasal administration has attracted considerable research interest as an alternative method to conventional parenteral and oral routes, because it can increase the drug concentrations in the brain by direct nose-to-brain delivery via olfactory and trigeminal nerve pathways. This additionally ensures a rapid onset of action, it circumvents hepatic first-pass effects, and provides a patient-friendly administration route. 7,12,13 To increase the efficacy of nose-to-brain delivery, nanoparticles have emerged as promising carriers because of their remarkable capacity to facilitate drug transportation. 14 Nanoparticles improve drug stability by encapsulating them within a matrix and pro -Abstract Truncated-

Primary Studies on Construction and Evaluation of Ion-Sensitive in situ Gel Loaded with Paeonol-Solid Lipid Nanoparticles for Intranasal Drug Delivery

The Brain Targeting Efficiency Following Nasally Applied Mpeg-Pla Nanoparticles In Rats

An Available Strategy for Nasal Brain Transport of Nanocomposite Based on PAMAM Dendrimers Via in Situ Gel

Poly (ethylene glycol)-block-poly (D, L-lactide) (PEG-PLA) micelles for brain delivery of baicalein through nasal route for potential treatment of neurodegenerative diseases due to oxidative stress and inflammation: An in vitro and in vivo study

Solanum Tuberosum Lectin-Conjugated Plga Nanoparticles for Nose-To-Brain Delivery: in Vivo and in Vitro Evaluations

Recent Advances in Intranasal Administration for Brain-Targeting Delivery: A Comprehensive Review of Lipid-Based Nanoparticles and Stimuli-Responsive Gel Formulations

Preparation, In Vitro and In Vivo Evaluation of Nanoemulsion In Situ Gel for Transnasal Delivery of Traditional Chinese Medicine Volatile Oil from Ligusticum sinense Oliv.cv. Chaxiong

Low Molecular Weight Protamine-Functionalized Nanoparticles for Drug Delivery to the Brain after Intranasal Administration

Lactoferrin-modified PEG-co-PCL Nanoparticles for Enhanced Brain Delivery of NAP Peptide Following Intranasal Administration

Intranasal administration of silibinin-loaded pullulan acetate nanocarriers: A pH-responsive approach for brain targeting in Alzheimer's disease

Preparation of surface multiple-coated polylactide acid drug-loaded nanoparticles for intranasal delivery and evaluation on its brain-targeting efficiency.

Evaluation of paeonol skin-target delivery from its microsponge formulation: in vitro skin permeation and in vivo microdialysis

Preparation of Nimodipine-Loaded Microemulsion for Intranasal Delivery and Evaluation on the Targeting Efficiency to the Brain

Investigation of the "Nose-to-Brain" Pathways in Intranasal HupA Nanoemulsions and Evaluation of Their in vivo Pharmacokinetics and Brain-Targeting Ability

Brain delivery of vasoactive intestinal peptide enhanced with the nanoparticles conjugated with wheat germ agglutinin following intranasal administration.

In vitro evaluation and in situ intestinal absorption characterisation of paeoniflorin nanoparticles in a rat model

Preparation and Evaluation of Lecithin/zein Hybrid Nanoparticles for the Oral Delivery of Panax Notoginseng Saponins.

Lipid nanoparticles for intranasal administration: application to nose-to-brain delivery

In situ hydrogel containing diazepam-loaded nanostructured lipid carriers (DZP-NLC) for nose-to-brain delivery: development, characterization and deposition studies in a 3D-printed human nasal cavity model

Preparation, physicochemical characterization, ex vivo , and in vivo evaluations of asiatic acid-loaded solid lipid nanoparticles formulated with natural waxes for nose-to-brain delivery

Development and Characterization of n-Propyl Gallate Encapsulated Solid Lipid Nanoparticles-Loaded Hydrogel for Intranasal Delivery